For glycemic control, these medications typically reduce HbA1c by 1.0-2.0% in patients with type 2 diabetes
GLP-1 receptor agonists are designed for subcutaneous administration only, typically into the abdomen, thigh, or upper arm
The art of tissue-specific and disease-specific dosing may emerge in the not-too-distant future: Rather than using the current pharmacologic doses of GLP-1s to soak receptors throughout the body, we may learn how to apply much more tailored brush strokes to effectively treat, say, dementia or rheumatoid arthritis
Lastly, I went through various weight loss protocols, the cost of the diet, and the time it takes to achieve weight loss
Liraglutide (Saxenda, Victoza) Liraglutide is a daily GLP-1 medication with a 13-hour half-life
Its using carefully calibrated amounts of medications like semaglutide and tirzepatide (the active pharmaceutical ingredient found in Ozempic, Wegovy, Mounjaro, and Zepbound) that may support metabolic function, reduce inflammation, and promote cardiovascular health without substantial weight change